Showing results (1751-1760 of 2,100) with videos related to

Sort By:
Pageof 210
Protein Science : a Publication of the Protein Society|November 21, 2025
Membrane binding of a cyanobacterial ESCRT-III protein crucially involves the helix α1-3 hairpin conserved in all superfamily membersLukas Schlösser, Mirka Kutzner, Nadja Hellmann, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 5, 2018
Negative association of antibiotics on clinical activity of immune checkpoint inhibitors in patients with advanced renal cell and non-small-cell lung cancerL Derosa, M D Hellmann, M Spaziano, et al.
Nature Communications|June 4, 2016
Large-scale ordering of nanoparticles using viscoelastic shear processingQibin Zhao, Chris E Finlayson, David R E Snoswell, et al.
Annals of Hematology|April 28, 2005
A multicenter, open, noncomparative, phase II study of the combination of cladribine (2-chlorodeoxyadenosine), cytarabine, granulocyte colony-stimulating factor and mitoxantrone as induction therapy in refractory acute myeloid leukemia: a report of the Polish Adult Leukemia GroupA Wrzesień-Kuś, T Robak, A Wierzbowska, et al.
AIDS (London, England)|April 24, 2001
Sequencing of protease inhibitor therapy: insights from an analysis of HIV phenotypic resistance in patients failing protease inhibitorsC A Kemper, M D Witt, P H Keiser, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 27, 2018
Tumor Mutation Burden and Efficacy of EGFR-Tyrosine Kinase Inhibitors in Patients with EGFR-Mutant Lung CancersMichael Offin, Hira Rizvi, Megan Tenet, et al.
Cancer Medicine|May 7, 2020
Radiation pneumonitis in lung cancer patients treated with chemoradiation plus durvalumabNarek Shaverdian, Maria Thor, Annemarie F Shepherd, et al.
Science Advances|November 23, 2022
Widespread hypertranscription in aggressive human cancersMatthew Zatzman, Fabio Fuligni, Ryan Ripsman, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 9, 2016
Clinical outcomes with pemetrexed-based systemic therapies in RET-rearranged lung cancersA Drilon, I Bergagnini, L Delasos, et al.
European Journal of Cancer (Oxford, England : 1990)|January 30, 2004
Second malignancies and Richter's syndrome in patients with chronic lymphocytic leukaemia treated with cladribineT Robak, J Z Blonski, J Gora-Tybor, et al.
Pageof 210